Want to see NZ:EBO full AI Analyst Report?
EBOS Group Limited (EBO) Stock Price & Analysis
EBO Stock Chart & Stats
- Day’s Range
- NZD 20.40 - NZD 21.37
- 52-Week Range
- NZD 18.45 - NZD 29.50
- Previous Close
- NZD 20.50
- Volume
- N/A
- Average Volume (3M)
- 169.57K
- Market Cap
- NZD 4.29B
- Enterprise Value
- NZD 6.29B
- Total Cash (Recent Filing)
- NZD 239.29M
- Total Debt (Recent Filing)
- NZD 1.90B
- Price to Earnings (P/E)
- 15.9
- Beta
- 0.93
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- 0.66
- Last Dividend Ex-Date
- Aug 27, 2026
- Dividend Yield
- 6.01%
Bulls Say, Bears Say
Bulls Say
Diversified Healthcare Distribution Platform
EBOS serves essential healthcare and animal-care channels across Australia and New Zealand, reducing reliance on any single customer group. Its broad product range, established relationships and recurring demand support a durable distribution platform and ongoing relevance to providers.
Distribution Infrastructure Productivity And Lower Capital Needs
Completion of the distribution-centre renewal program strengthens operating capacity while reducing the need for similarly elevated investment. Further productivity gains at Kemps Creek could support scalable growth, better asset utilisation and structurally stronger cash generation.
Growth Divisions And Financial Flexibility
Strong Animal Care growth broadens EBOS’s earnings base, while FY27 guidance indicates continued underlying EBITDA expansion. Moderate leverage, substantial committed liquidity and expected lower CapEx provide flexibility to fund bolt-on acquisitions and sustain investment.
Bears Say
Revenue And Margin Volatility
The sharp FY2026 revenue contraction and material gross-margin compression weaken confidence in the stability of EBOS’s earnings profile. Even with broadly flat net income, this volatility can make planning, capital allocation and sustainable margin assessment more difficult.
Community Pharmacy Margin Pressure
Persistent competition and margin pressure in Community Pharmacy could constrain profitability in an important operating channel. With a relatively low group EBITDA margin, continued pricing or mix pressure may limit earnings conversion even if healthcare demand and sales volumes remain resilient.
New Zealand Contract Roll-off
The scheduled loss of a major New Zealand wholesaling contract creates a defined source of earnings pressure over the next several months. Redeployment or restructuring may offset some impact, but replacement revenue and capacity utilisation are not assured by the stated evidence.
EBOS Group Limited News
EBO FAQ
What was EBOS Group Limited’s price range in the past 12 months?
What is EBOS Group Limited’s market cap?
When is EBOS Group Limited’s upcoming earnings report date?
How were EBOS Group Limited’s earnings last quarter?
Is EBOS Group Limited overvalued?
Does EBOS Group Limited pay dividends?
What is EBOS Group Limited’s EPS estimate?
How many shares outstanding does EBOS Group Limited have?
What happened to EBOS Group Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of EBOS Group Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
EBOS Group Limited
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Adam Luke Hall
- Employees
- 5,364
- Website
- www.ebosgroup.com
- Address
- 737 Bourke Street, Docklands, VIC, 3008, AU
EBOS Group Limited (EBO) Earnings & Revenues
EBO Earnings Call
Earnings Call SentimentPositive
The call communicated solid top‑line growth, completion of a major A$360m infrastructure program that materially reduces future capital needs, meaningful momentum in higher-growth divisions (Animal Care, Medical Technology, Retail Pharmacy Brands) and a disciplined M&A and capital allocation approach. Temporary headwinds were acknowledged — notably FX translation, fuel costs, margin pressure and a known NZ contract roll-off — but management framed these as manageable or transitory and backed guidance that excludes further acquisitions. Balance sheet metrics, free cash flow generation and a maintained dividend were highlighted as strengths. Overall the positives (portfolio re‑positioning, completed investment cycle, strong divisional growth and capital flexibility) outweigh the measurable but contained lowlights.
View all NZ:EBO earnings summariesEBO Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 5 | 4 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 11 | 0 | 1 |
